Heiner C. Bucher
-
- Antibiotic Use and Resistance 19
- Virology top 0.5%
- HIV Research and Treatment 44
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions 64
- HIV/AIDS drug development and treatment 56
- Emergency Medicine top 0.2%
- HIV-related health complications and treatments 36
-
- Health Systems, Economic Evaluations, Quality of Life 26
-
- Pneumocystis jirovecii pneumonia detection and treatment 16
- Pneumonia and Respiratory Infections 16
- Co-authors
- Matthias BrielGordon GuyattLauren E. GriffithStephen D. WalterAlain NordmannPeter HengstlerChristian SchindlerTracy R. Glass
- Partner nations
- SwitzerlandUnited StatesCanada
In The Last Decade
Heiner C. Bucher
247 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 190
- Applied Microbiology and Biotechnology 562
- Virology 1.2k
- Infectious Diseases 2.8k
- Critical Care and Intensive Care Medicine 775
- Emergency Medicine 1.3k
Countries citing papers authored by Heiner C. Bucher
This map shows the geographic impact of Heiner C. Bucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiner C. Bucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiner C. Bucher more than expected).
Fields of papers citing papers by Heiner C. Bucher
This network shows the impact of papers produced by Heiner C. Bucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiner C. Bucher. The network helps show where Heiner C. Bucher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Heiner C. Bucher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 15 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 16 | |
| 6 | 2017 | 28 | |
| 7 | 2017 | 2 | |
| 8 | 2016 | 24 | |
| 9 | 2015 | 13 | |
| 10 | 2013 | 73 | |
| 11 | 2011 | 71 | |
| 12 | 2010 | 6 | |
| 13 | 2008 | 88 | |
| 14 | Abstract 1688: Impact of Change in High-Density Lipoprotein Cholesterol on Cardiovascular Disease Morbidity and Mortality: Systematic Review and Meta-Regression Analysis | 2008 | 2 |
| 15 | 2005 | 170 | |
| 16 | 2004 | 7 | |
| 17 | 2002 | 21 | |
| 18 | 1999 | 27 | |
| 19 | [Compliance of asylum seekers with an expanded border health screening program in the Basel-Stadt canton 1992-1993]. | 1994 | 3 |
| 20 | [Health behavior and social inequality in the Swiss population. Results from the SOMIPOPS study (Sociomedical Model Indicators of the Population of Switzerland)]. | 1987 | 4 |
About Heiner C. Bucher
Heiner C. Bucher is a scholar working on Applied Microbiology and Biotechnology, Virology and Infectious Diseases, having authored 253 papers that have together received 15.0k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (64 papers), HIV/AIDS drug development and treatment (56 papers), HIV Research and Treatment (44 papers), HIV-related health complications and treatments (36 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers), Antibiotic Use and Resistance (19 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers) and Pneumonia and Respiratory Infections (16 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (562 citations), Virology (1.2k citations) and Infectious Diseases (2.8k citations). Heiner C. Bucher has collaborated with scholars based in Switzerland, United States and Canada. Frequent co-authors include Matthias Briel, Gordon Guyatt, Lauren E. Griffith, Stephen D. Walter, Alain Nordmann, Peter Hengstler, Christian Schindler, Tracy R. Glass, Viktoria Gloy and Manuel Battegay. Their work appears in journals such as The Lancet, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.